Cargando…
SA43 Rapid Evidence Publication in the COVID-19 Era: Impact on Study Quality and Study Identification
Autores principales: | Wright, C, Misso, K, Green, R, Marjenberg, Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747475/ http://dx.doi.org/10.1016/j.jval.2022.09.2437 |
Ejemplares similares
-
SA43 The Impact of COVID-19 on Managing Clinical Trials
por: Gannavarapu, PP, et al.
Publicado: (2022) -
Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis
por: Marjenberg, Zoe, et al.
Publicado: (2023) -
Rapid publications risk the integrity of science in the era of COVID-19
por: Bagdasarian, N., et al.
Publicado: (2020) -
Development of evidence-based clinical practice guidelines (CPGs): comparing approaches
por: Turner, Tari, et al.
Publicado: (2008) -
Sa012 CORNEAL ABRASIONS DURING ENDOSCOPIC PROCEDURES IN THE COVID-19 ERA ARE A PREVENTABLE PHENOMENON: A QUALITY IMPROVEMENT PROJECT
por: Haghighat, Shida, et al.
Publicado: (2021)